Malignant Liver Tumours: Basic Concepts and Clinical Management

Author:   F. Berr ,  J. Bruix ,  J. Hauss ,  Ch. Wittekind
Publisher:   Kluwer Academic Publishers
Edition:   2003 ed.
Volume:   127A
ISBN:  

9780792387794


Pages:   224
Publication Date:   30 November 2002
Format:   Hardback
Availability:   Awaiting stock   Availability explained


Our Price $332.64 Quantity:  
Add to Cart

Share |

Malignant Liver Tumours: Basic Concepts and Clinical Management


Overview

Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC), both increasing in incidence, have become a major topic of basic and clinical research as well as clinical practice in hepatology. Experts in the field update the current concepts on the carcinogenesis of HCC and CC such as genetic alterations in the pathways of cell cylce and apoptosis regulation, the hypothesis of dedifferentiation of hepatocytes to the malignant phenotype vs that of activation of hepatic progenitor cells incapable of maturation (maturation arrest hypothesis). In spite of an increasing number of genetic alterations described in human HCC as well as cell regulatory pathways tested in experimental HCC models, the key hits causing progression of the cell cycle in imbalance with apoptosis, tissue invasive growth and metastatic potential of cell clones still remain elusive. Very powerful genomic and proteomic techniques are promising insights into the carcinogenesis of liver malignancies that will allow more efficient therapeutic strategies. The current concepts on risk profiling, surveillance of risk groups and therapeutic strategies are evidence-based for HCC and less detailed for CC. Surveillance of risk groups improves detection of liver tumours in curable stages. Best strategies for curative treatment of HCC use neoadjuvant antitumour therapies before liver transplantation and a role is emerging for living donor-related liver transplantation. New palliative therapies for HCC are in the experimental stage with biological response modifiers, including angiogenesis inhibitors, and entering phase II clinical trials with the alpha-fetoprotein derived vaccines. This book, the proceedings of Falk Workshop No. 127, held in Leipzig, Germany, January 24-25, 2002 (as Pre-meeting of the Annual Meeting of the German Association for the Study of the Liver) summarizes the expert knowledge on the carcinogenesis, surveillance of risk groups, and clinical management of malignant liver tumours.

Full Product Details

Author:   F. Berr ,  J. Bruix ,  J. Hauss ,  Ch. Wittekind
Publisher:   Kluwer Academic Publishers
Imprint:   Kluwer Academic Publishers
Edition:   2003 ed.
Volume:   127A
Dimensions:   Width: 15.60cm , Height: 1.40cm , Length: 23.40cm
Weight:   0.485kg
ISBN:  

9780792387794


ISBN 10:   0792387791
Pages:   224
Publication Date:   30 November 2002
Audience:   College/higher education ,  Professional and scholarly ,  Postgraduate, Research & Scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Out of Stock Indefinitely
Availability:   Awaiting stock   Availability explained

Table of Contents

Reviews

Author Information

Tab Content 6

Author Website:  

Countries Available

All regions
Latest Reading Guide

NOV RG 20252

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List